LONDON: BioPharma Credit PLC, a leading debt investment trust listed on the London Stock Exchange (LSE: BPCR), has declared a substantial financial agreement through its wholly owned subsidiary and in conjunction with BioPharma Credit Investments V (Master) LP. The partnership has secured a senior loan agreement with Novocure Luxembourg S.a.r.l., a subsidiary of the NASDAQ-listed…
Tag: Biopharma Credit
BioPharma Credit to invest $325mn in Collegium Pharmaceuticals
LONDON, UK: BioPharma Credit (LSE: BPCR) t, through its fully owned subsidiary, together with BioPharma Credit Investments V (Master) LP, has provided Collegium Pharmaceutical Inc. (Nasdaq: COLL) a commitment to enter into a new $650 million senior secured term loan agreement. Proceeds from the new loan will be used to fund Collegium’s proposed acquisition of…
Biopharma Credit Plc announces new investment
LONDON: BioPharma Credit along with its subsidiary BioPharma-V has entered into a US$300 million definitive senior secured loan agreement with LumiraDx Investment Limited and LumiraDx Group Limited. The Company will invest US$150 million and BioPharma-V will invest an additional US$150 million. Based in the UK, LumiraDx is a next-generation point of care, or POC, diagnostic…